AHNS 2015 Translational Research Post-Meeting Survey

The 2015 Program Committee requests that you take this post-meeting survey regarding your recent participation at the AHNS 2015 Translational Research meeting. Your responses are required in order to obtain CME credit for this meeting.

Thank you for attending the meeting.

	Poor	Mediocre	Neutral	Good	Excellent
Application to your Practice	Application to your Practice Poor	Application to your Practice Mediocre	Application to your Practice Neutral	Application to your Practice Good	Application to your Practice Excellent
Quality of the presentations	Quality of the presentations Poor	Quality of the presentations Mediocre	Quality of the presentations Neutral	Quality of the presentations Good	Quality of the presentations Excellent
Meeting Course and Session Objectives	Meeting Course and Session Objectives Poor	Meeting Course and Session Objectives Mediocre	Meeting Course and Session Objectives Neutral	Meeting Course and Session Objectives Good	Meeting Course and Session Objectives Excellent
Overall meeting rating	Overall meeting rating Poor	Overall meeting rating Mediocre	Overall meeting rating Neutral	Overall meeting rating Good	Overall meeting rating Excellent

Poor

Mediocre

Neutral

Good

Excellent

Application to your Practice

Application to your Practice Poor

Application to your Practice Mediocre

Application to your Practice Neutral

Application to your Practice Good

Application to your Practice Excellent

Quality of the presentations

Quality of the presentations Poor

Quality of the presentations Mediocre

Quality of the presentations Neutral

Quality of the presentations Good

Quality of the presentations Excellent

Meeting Course and Session Objectives

Meeting Course and Session Objectives Poor

Meeting Course and Session Objectives Mediocre

Meeting Course and Session Objectives Neutral

Meeting Course and Session Objectives Good

Meeting Course and Session Objectives Excellent

Overall meeting rating

Overall meeting rating Poor

Overall meeting rating Mediocre

Overall meeting rating Neutral

Overall meeting rating Good

Overall meeting rating Excellent

	1 - Not at all better	2	3 - Neutral	4	5 - Significantly better	N/A
Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design 1 - Not at all better	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design 2	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design 3 - Neutral	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design 4	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design 5 - Significantly better	Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial design N/A
Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials 1 - Not at all better	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials 2	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials 3 - Neutral	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials 4	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials 5 - Significantly better	Understand that massive sequencing and molecular data exists and use this data to form hypotheses, to design pre-clinical experiments and to translate results into clinical trials N/A
Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients 1 - Not at all better	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients 2	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients 3 - Neutral	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients 4	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients 5 - Significantly better	Be aware of existing and developing technology for minimally invasive surgery and implement currently available tools for care of patients N/A
Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac 1 - Not at all better	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac 2	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac 3 - Neutral	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac 4	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac 5 - Significantly better	Recognize existing best practices based on outcome studies and integrate them into current multi-disciplinary practices at their institutions or prac N/A
Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types 1 - Not at all better	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types 2	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types 3 - Neutral	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types 4	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types 5 - Significantly better	Assess the potential value of immuno-modulatory and combinatorial targeted therapy in HNSCC based on progress made with other tumor types N/A
Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 1 - Not at all better	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 2	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 3 - Neutral	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 4	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 5 - Significantly better	Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy N/A

1 - Not at all better

3 - Neutral

5 - Significantly better

N/A

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design 1 - Not at all better

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design 2

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design 3 - Neutral

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design 4

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design 5 - Significantly better

Integrate molecular testing for HPV and other HNSCC subtypes into practice and/or trial
design N/A

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials 1 - Not at all better

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials 2

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials 3 - Neutral

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials 4

Understand that massive sequencing and molecular data exists and use this data to form
hypotheses, to design pre-clinical experiments and to translate results into clinical trials N/A

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients 1 - Not at all better

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients 2

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients 3 - Neutral

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients 4

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients 5 - Significantly better

Be aware of existing and developing technology for minimally invasive surgery and
implement currently available tools for care of patients N/A

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac 1 - Not at all better

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac 2

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac 3 - Neutral

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac 4

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac 5 - Significantly better

Recognize existing best practices based on outcome studies and integrate them into current
multi-disciplinary practices at their institutions or prac N/A

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types 1 - Not at all better

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types 2

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types 3 - Neutral

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types 4

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types 5 - Significantly better

Assess the potential value of immuno-modulatory and combinatorial targeted therapy in
HNSCC based on progress made with other tumor types N/A

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 1 - Not at all better

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 2

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 3 - Neutral

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 4

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy 5 - Significantly better

Participate in pre-clinical or clinical research to increase understanding of HNSCC immuno-modulatory and combinatorial targeted therapy N/A

AHNS 2015 Translational Research Post-Meeting Survey

1. AHNS 2015 Translational Research Post-Meeting Survey

Question Title

* 1. How did we do overall?

Question Title

* 2. Please indicate if you feel better able to do the following as a result of this meeting:

Question Title

* 3. Will the information presented during the meeting lead you to change your practice in any way?